STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 61 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $7,267,000 | -16.8% | 495,384 | +15.5% | 0.01% | -12.5% |
| Q1 2014 | $8,736,000 | +17.4% | 429,078 | +13.0% | 0.01% | +14.3% |
| Q4 2013 | $7,443,000 | -58.6% | 379,741 | -4.3% | 0.01% | -61.1% |
| Q3 2013 | $17,963,000 | +154.0% | 396,619 | +33.7% | 0.02% | +157.1% |
| Q2 2013 | $7,073,000 | – | 296,693 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 220,000 | $9,965,000 | 0.68% |
| Healthcare Value Capital, LLC | 16,464 | $746,000 | 0.65% |
| EAM Investors, LLC | 69,151 | $3,132,000 | 0.62% |
| Baker Brothers Advisors | 800,400 | $36,255,000 | 0.52% |
| Spark Investment Management LLC | 38,300 | $1,733,000 | 0.40% |
| Perceptive Advisors | 180,416 | $8,172,000 | 0.34% |
| SIGMA CAPITAL MANAGEMENT LLC | 175,000 | $7,926,000 | 0.33% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 129,915 | $5,885,000 | 0.23% |
| Visium Asset Management, LP | 150,000 | $6,794,000 | 0.15% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 19,732 | $894,000 | 0.14% |